FTC Issues Warning to Healthcare Marketers Over Deceptive Claims
Click to Enlarge
The Federal Trade Commission (FTC) has issued warning letters to 21 healthcare marketers regarding deceptive claims in promoting healthcare-related products, signaling a strong stance on consumer protection. The warnings come amidst heightened attention on healthcare companies, including public frustrations over claim denials and rising healthcare costs, which are projected to increase by 10.2% in 2025.
While the FTC did not publicly name the companies receiving letters, it emphasized that misrepresenting healthcare products’ benefits, costs, or comprehensiveness violates Section 5(a) of the FTC Act. The agency referenced prior enforcement actions, including a $195 million judgment against Simple Health Plans and an $8.7 million ruling against Partners in Healthcare Association, both of which were found guilty of falsely marketing limited benefit programs as comprehensive health insurance.
These warnings call on healthcare marketers to immediately review their advertising practices to ensure compliance with federal regulations. The FTC underscored that failure to comply could have serious legal consequences, such as federal lawsuits.
The healthcare industry, already grappling with rising costs, workforce shortages, and inflation, is now under added scrutiny to maintain ethical transparency in marketing practices. Physicians and healthcare leaders are encouraged to remain vigilant and educate their patients on identifying misleading claims. For further updates on federal regulations and compliance, visit the FTC’s website.
FTC warns 21 healthcare marketers against deceptive claims (Sadovi, HealthcareDive, 12/10).
